| UHC Surest Medical and Drug | Hearing Aids and Devices Including Wearable, Bone-Anchored, and Semi-Implantable - Commercial and Individual Exchange Medical Policy | 2026-03-01 |
| UHC Surest Medical and Drug | Intensity-Modulated Radiation Therapy - Commercial and Individual Exchange Medical Policy | 2026-03-01 |
| UHC Surest Medical and Drug | Lower Extremity Endovascular Procedures - Commercial and Individual Exchange Medical Policy | 2026-03-01 |
| UHC Surest Medical and Drug | Proton Beam Radiation Therapy - Commercial and Individual Exchange Medical Policy | 2026-03-01 |
| UHC Surest Medical and Drug | Radiation Therapy: Fractionation, Image-Guidance, and Special Services - Commercial and Individual Exchange Medical Policy | 2026-03-01 |
| UHC Surest Medical and Drug | Review at Launch for New to Market Medications - Commercial Medical Benefit Drug Policy | 2026-03-01 |
| UHC Surest Medical and Drug | Ryplazim® (Plasminogen, Human-Tvmh) - Commercial Medical Benefit Drug Policy | 2026-03-01 |
| UHC Surest Medical and Drug | Simponi Aria® (Golimumab) Injection for Intravenous Infusion - Commercial Medical Benefit Drug Policy | 2026-03-01 |
| UHC Surest Medical and Drug | Surgery of the Hip - Commercial and Individual Exchange Medical Policy | 2026-03-01 |
| UHC Surest Medical and Drug | Surgery of the Knee - Commercial and Individual Exchange Medical Policy | 2026-03-01 |